AgriFutures Chicken Meat Program RD&E Snapshot
As we head into a new research, development and extension (RD&E) period for the Australian chicken meat industry (2022–2027), it is timely to reflect on...
Published: 16 Sep 2014
Author(s): Devlin, Joanne
Download report PDFDownload
Purchase a hard copy - AUD $45.00
The report describes the results from a pilot study examining the use of an attenuated strain of infectious laryngotracheitis virus (ILTV, gallid herpesvirus 1) as a vector to express antigen from infectious bronchitis virus (IBV). This work was undertaken to assess the feasibility of using this attenuated ILTV strain as a vaccine vector.